Northern Trust’s C4 Therapeutics CCCC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $200K | Sell |
139,673
-360,095
| -72% | -$515K | ﹤0.01% | 3938 |
|
|
2025
Q1 | $800K | Buy |
499,768
+4,725
| +1% | +$7.56K | ﹤0.01% | 3375 |
|
|
2024
Q4 | $1.78M | Buy |
495,043
+5,223
| +1% | +$18.8K | ﹤0.01% | 3091 |
|
|
2024
Q3 | $2.79M | Buy |
489,820
+310,247
| +173% | +$1.77M | ﹤0.01% | 2793 |
|
|
2024
Q2 | $830K | Buy |
179,573
+70,895
| +65% | +$328K | ﹤0.01% | 3325 |
|
|
2024
Q1 | $888K | Buy |
108,678
+1
| +0% | +$8 | ﹤0.01% | 3370 |
|
|
2023
Q4 | $614K | Buy |
108,677
+17,685
| +19% | +$99.9K | ﹤0.01% | 3473 |
|
|
2023
Q3 | $169K | Sell |
90,992
-166
| -0.2% | -$309 | ﹤0.01% | 3876 |
|
|
2023
Q2 | $251K | Sell |
91,158
-293,446
| -76% | -$807K | ﹤0.01% | 3737 |
|
|
2023
Q1 | $1.21M | Sell |
384,604
-14,428
| -4% | -$45.3K | ﹤0.01% | 3160 |
|
|
2022
Q4 | $2.35M | Buy |
399,032
+17,049
| +4% | +$101K | ﹤0.01% | 2913 |
|
|
2022
Q3 | $3.35M | Buy |
381,983
+11,463
| +3% | +$101K | ﹤0.01% | 2725 |
|
|
2022
Q2 | $2.79M | Buy |
370,520
+21,258
| +6% | +$160K | ﹤0.01% | 2865 |
|
|
2022
Q1 | $8.47M | Sell |
349,262
-12,434
| -3% | -$302K | ﹤0.01% | 2254 |
|
|
2021
Q4 | $11.6M | Sell |
361,696
-2,257
| -0.6% | -$72.7K | ﹤0.01% | 2129 |
|
|
2021
Q3 | $16.3M | Buy |
363,953
+60,574
| +20% | +$2.71M | ﹤0.01% | 1938 |
|
|
2021
Q2 | $11.5M | Buy |
303,379
+184,303
| +155% | +$6.97M | ﹤0.01% | 2272 |
|
|
2021
Q1 | $4.41M | Sell |
119,076
-5,994
| -5% | -$222K | ﹤0.01% | 2834 |
|
|
2020
Q4 | $4.14M | Buy |
+125,070
| New | +$4.14M | ﹤0.01% | 2786 |
|